AbbVie, in collaboration with adMare BioInnovations, is offering young biotechnology companies the …
CQDM, with the support of MEIE under the AReNA program, is funding Quebec-based companies to…
Quantum Leap supports SMEs and universities in carrying out translational biopharmaceutical research…
SynergiQc, our biopharmaceutical R&D funding program, is designed to support innovation in …
EncephalX, a Canadian medtech company, has closed a CAD $2.25M oversubscribed pre-seed round to…
adMare BioInnovations is proud to announce the creation of Ocythera, a new biopharmaceutical company dedicated to…
AbbVie (NYSE: ABBV), a global research and development biopharmaceutical company, announced the…
We use cookies to improve your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Privacy Policy